Mira Dx Launches Ovarian Cancer Risk Test

The test, dubbed PreOvar, identifies women at increased risk of developing ovarian cancer based on a genetic variant that affects a key microRNA.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.